Screener
Integra LifeSciences IART Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Other liabilities | 194,397 | 204,278 |
| Total liabilities | 2,520,113 | 2,558,538 |
| Stockholders’ equity: | ||
| Preferred stock; no par value; 15,000 authorized shares; none outstanding | — | — |
| Common stock; $0.01 par value; 240,000 authorized shares; 92,130 and 92,286 issued at June 30, 2026 and December 31, 2025, respectively | 921 | 923 |
| Additional paid-in capital | 1,346,265 | 1,338,386 |
| Treasury stock, at cost; 14,351 shares and 14,399 shares at June 30, 2026 and December 31, 2025, respectively | (686,918) | (689,210) |
| Accumulated other comprehensive loss | (40,197) | (30,077) |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's preferred stock, shares authorized?
- Integra LifeSciences (IART) reported preferred stock, shares authorized of $15M in Q2 2026.
- How has Integra LifeSciences's preferred stock, shares authorized changed year-over-year?
- Integra LifeSciences's preferred stock, shares authorized decreased by 0.0% year-over-year, from $15M to $15M.
- What is the long-term trend for Integra LifeSciences's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Integra LifeSciences's preferred stock, shares authorized has grown at a 298.1% compound annual growth rate (CAGR), from $15K to $15M.
Ask your AI about Integra LifeSciences's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude